LIC MF Equity Savings Fund
The scheme seeks to provide regular income by investing in debt and money market instruments and using arbitrage and other derivative strategies. Also intends to generate long capital appreciation through unhedged exposure to equity and equity related instruments.
Growthvine rating: 1/5 — ranked #21 of 25 in category.
Fund basics
| Category | Hybrid: Equity Savings |
|---|
| NAV | ₹28.14 (as of 2026-10-01) |
|---|
| AUM | ₹38 Cr |
|---|
| Expense ratio | 1.99% |
|---|
| Riskometer | Moderately High |
|---|
| Fund manager | Siddharth Panjwani |
|---|
| Exit load | For units in excess of 12% of the investment, 1% will be charged for redemption within 3 months |
|---|
Performance & risk
| Sharpe ratio | 0.37 |
|---|
| Standard deviation | 7.15% |
|---|
| Max drawdown | −7.67% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 128.0% of NIFTY 50 Hybrid Short Duration Debt 25:75 Index's upside and 167.7% of its downside.
Market cap allocation
| Large cap | 63.0% |
|---|
| Mid cap | 28.8% |
|---|
| Small cap | 8.3% |
|---|
Concentration
| Top 5 holdings | 10.9% |
|---|
| Top 10 holdings | 19.4% |
|---|
| Total holdings | 86 |
|---|
Top holdings
- Net Receivable / Payable — 34.8%
- Treps — 20.5%
- LIC MF LIQUID FUND-DR PLN-GR — 9.7%
- Cipla Ltd. — 2.8%
- State Bank Of India — 2.5%
- Eternal Limited — 2.0%
- Ashok Leyland Ltd. — 1.8%
- APL Apollo Tubes Limited — 1.8%
- Bank Of Baroda — 1.8%
- Divis Laboratories Ltd. — 1.7%
Top sectors
Not disclosed.
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 0.1% | Q2 | #13 of 25 |
| 2025 | 7.3% | Q2 | #7 of 22 |
| 2024 | 8.9% | Q3 | #14 of 22 |